AFT Pharmaceuticals narrows 1H loss, sees return to profitability this year or next

AFT Pharmaceuticals narrows 1H loss, sees return to profitability this year or next
Rebecca Howard
By Rebecca Howard Nov. 23 (BusinessDesk) - AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, narrowed its first-half loss and said it is still on track to return to profitability this financial year or the next as it increases the number of markets where its products are sold.  The Auckland-based company reported a net loss of $6.9 million, or 7 cents per share, in the six months to Sept. 30 from a loss of $11 million, or 40 cents, in the prior period. Operating revenue was $36.6 million versus $29.8 million in the prior p...